Medical News

RSS

Cytori Therapeutics announces independent clinical study results in breast reconstruction presented at the Association of Breast Surgery conference

Cytori Therapeutics, Inc. (NASDAQ: CYTX) reports that surgeons from North Tees and Hartlepool NHS Foundation Trust have presented clinical outcomes using Adipose-Derived Regenerative Cell (ADRC) fat grafting in reconstructive breast surgery at the Association of Breast Surgery Conference in Manchester, UK, May 16-17, 2011. The procedure, referred to by Cytori as RESTORE, was separately investigated in Cytori’s own RESTORE 2 trial.

17 May 2011

Pioneer of ‘organ-on-a-chip’ technology to speak at Imperial College London

The potential of microscopic organ-on-a-chip devices that mimic the way real organs work, so that scientists and engineers can model the effects of therapies more accurately, will be discussed by a pioneer in bioengineering at Imperial College London this week.

17 May 2011

WFP resumes food aid operations in South Sudan

The World Food Program (WFP) has resumed food aid operations in South Sudan after operations were suspended last month because of violence, Reuters reports.

17 May 2011

Preliminary topline results from Teva, CureTech's CT-011 Phase II trial in Diffuse Large B Cell Lymphoma

Teva Pharmaceutical Industries Ltd. and CureTech, a portfolio company of Teva and Clal Biotechnology Industries announced today preliminary topline results for CT-011, an investigational anti-PD-1 monoclonal antibody.

17 May 2011

New A+PSA assay more accurately detects prostate cancer

A new test for prostate cancer that measures levels of prostate specific antigen (PSA) as well as six specific antibodies found in the blood of men with the disease was more sensitive and more specific than the conventional PSA test used today, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center.

17 May 2011

Study achieves 5-fold reduction in Tc-99m sestamibi dosage for molecular breast imaging

Published in the April issue of Journal of Nuclear Medicine, Gamma Medica, Inc. and Mayo Clinic of Rochester, MN document the achievement of a 5-fold reduction in the necessary dose of Tc-99m sestamibi to perform Molecular Breast Imaging (MBI). This achievement enables the new LumaGEM™ MBI System by Gamma Medica to deliver the same low radiation dose as digital screening mammography.

17 May 2011

Columbia Laboratories to be listed on NASDAQ Biotechnology Index

Columbia Laboratories, Inc. today announced the Company will be added to the NASDAQ Biotechnology Index.

17 May 2011

American Heart Association recognizes NIC as Platinum-Level Start! Fit-Friendly Company

NIC, a leading provider of online government services, is one of only two Kansas City metro companies to be recognized as a Platinum-Level Start! Fit-Friendly Company by the American Heart Association's Start! initiative for helping employees eat better and move more.

17 May 2011

ProBioGen, Life Technologies' new cell line development kits now available for biologic drug production

Life Technologies Corporation and ProBioGen AG today announced the availability of Gibco Freedom Cell Line Development Kits, a new line of royalty-free products that integrate cells, reagents, culture media and protocols to bring simplicity and flexibility, eliminating up to two months in the earliest stages of new biological drug development.

17 May 2011

Bioengineering students redesign pediatric mannequin

Rice University bioengineering students have modified a child-size training mannequin to give medical students hands-on pediatric experience so that real patients can be spared further stress and pain.

17 May 2011

Concern over vaccine safety prevents parents from vaccinating asthmatic children

Concern over vaccine safety is one of the primary factors preventing parents from having their asthmatic children vaccinated for influenza, or flu, according to Michigan researchers. Parents who do not vaccinate their children are also less likely to view flu as a"trigger" for their child's asthma, the researchers noted.

17 May 2011

Accumetrics' VerifyNow P2Y12 Test receives CE mark approval for prognostic use

Accumetrics, Inc., developer of the VerifyNow System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the VerifyNow P2Y12 Test is now CE marked for prognostic use in identifying patients with high residual platelet reactivity on antiplatelet therapy who are at greater risk for future cardiovascular events.

17 May 2011

LDC conference ends with 10-year action plan

The Fourth U.N. Conference on Least Developed Countries closed in Istanbul on Friday "with a number of recommendations seeking to halve, from 48 to 24, the number of LDCs during the next 10 years," the Guardian's "Global Development" blog reports.

17 May 2011

Phase 2 trial data of PET myocardial perfusion imaging with flurpiridaz F 18 presented at ICNC10

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced data from a Phase 2 clinical trial that demonstrated Positron Emission Tomography myocardial perfusion imaging with flurpiridaz F 18 provided superior image quality, diagnostic certainty and diagnostic performance for detecting coronary artery disease (CAD) compared to single photon emission computed tomography myocardial perfusion imaging, the current standard for the non-invasive detection of CAD.

17 May 2011

Over-activation of single gene promotes leukemia, but its loss causes liver cancer

An international team of researchers, led by scientists at the University of California, San Diego School of Medicine, and the Eastern Hepatobiliary Surgery Hospital in China, say a human gene implicated in the development of leukemia also acts to prevent cancer of the liver.

17 May 2011

Thrombolytic therapy linked to poor survival in pulmonary embolism patients with normal blood pressure

Although so-called clot-busting drugs are commonly used in the treatment of some patients with blood clots in the lungs, a new study conducted by researchers in Spain and the U.S. indicates the agents do not appear to be any more effective than traditional blood thinners for the majority of these patients.

17 May 2011

Virtual reality offers returning soldiers 'psychotherapy by computer' to treat PTSD

For those soldiers worried about the stigma associated with seeing a therapist, virtual reality applications for the treatment of post-traumatic stress disorder (PTSD) may be the alternative to the traditional "talk therapy."

17 May 2011

Scientists identify 'de novo' genetic mutations in autism spectrum disorder children

Scientists at the University of Washington (UW) Department of Genome Sciences have identified several sporadic or "de novo" genetic mutations in children with autism spectrum disorder. The researchers applied leading edge molecular biology techniques and massively parallel sequencing to simultaneously examine all of the protein coding portions of the genome, collectively called the exome.

17 May 2011

Business trends shape medical practices

Minnesota Public Radio reports that independent practices increasingly face an uphill battle while the Minneapolis Star Tribune notes that the "company doctor" is making a comeback in workplaces across the nation.

17 May 2011

Scientists make human stem cells without working on human embryos

Stem cell research courts both controversy and support in the community- depending on your viewpoint.

17 May 2011

Medical News

Cytori Therapeutics announces independent clinical study results in breast reconstruction presented at the Association of Breast Surgery conference

Pioneer of ‘organ-on-a-chip’ technology to speak at Imperial College London

WFP resumes food aid operations in South Sudan

Preliminary topline results from Teva, CureTech's CT-011 Phase II trial in Diffuse Large B Cell Lymphoma

New A+PSA assay more accurately detects prostate cancer

Study achieves 5-fold reduction in Tc-99m sestamibi dosage for molecular breast imaging

Columbia Laboratories to be listed on NASDAQ Biotechnology Index

American Heart Association recognizes NIC as Platinum-Level Start! Fit-Friendly Company

ProBioGen, Life Technologies' new cell line development kits now available for biologic drug production

Bioengineering students redesign pediatric mannequin

Concern over vaccine safety prevents parents from vaccinating asthmatic children

Accumetrics' VerifyNow P2Y12 Test receives CE mark approval for prognostic use

LDC conference ends with 10-year action plan

Phase 2 trial data of PET myocardial perfusion imaging with flurpiridaz F 18 presented at ICNC10

Over-activation of single gene promotes leukemia, but its loss causes liver cancer

Thrombolytic therapy linked to poor survival in pulmonary embolism patients with normal blood pressure

Virtual reality offers returning soldiers 'psychotherapy by computer' to treat PTSD

Scientists identify 'de novo' genetic mutations in autism spectrum disorder children

Business trends shape medical practices

Scientists make human stem cells without working on human embryos

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News